AAREY DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹419 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr | ₹355 Cr |
What is the latest Revenue of AAREY DRUGS & PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹419 Cr |
Mar2023 | ₹493 Cr |
Mar2022 | ₹34,841,641 Cr |
Mar2021 | ₹300 Cr |
Mar2020 | ₹355 Cr |
How is Revenue of AAREY DRUGS & PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹419 Cr | -14.98 | |
Mar2023 | ₹493 Cr | -100.00 | |
Mar2022 | ₹34,841,641 Cr | 11,610,336.07 | |
Mar2021 | ₹300 Cr | -15.40 | |
Mar2020 | ₹355 Cr | - |
Compare Revenue of peers of AAREY DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AAREY DRUGS & PHARMACEUTICALS | ₹132.1 Cr | -3.6% | -13.5% | -4.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AAREY DRUGS & PHARMACEUTICALS | -3.6% |
-13.5% |
-4.7% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses